BSE filing, NSE: SOLARA. Summary written from the filing by ALFA Finder's alert engine.
Solara Active Pharma Sciences Ltd: key numbers
- Share price
- ₹653.80
- Market cap
- ₹3,149 Cr
- Revenue (annual)
- ₹1,369 Cr
- Net profit (annual)
- ₹-7.41 Cr
- P/E (TTM)
- 85.3×Sector 46.1×
- Promoter holding
- 41.93%+0.00% QoQ
- FII holding
- 10.71%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Solara Active Pharma Sciences Ltd
All →Solara Active Pharma Sciences Other Announcement
Solara Active Pharma Sciences Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This disclosure details equity ownership across various investor categories.
Solara Active Pharma Sciences Earnings Call Transcript: Key Takeaways
Solara delivered its best profitability in five years despite ongoing Ibuprofen pricing and raw material challenges.
Solara Active Pharma Sciences Investor Presentation: Key Takeaways
Solara's Q2 FY27 delivered record EBITDA and PAT in five years, driven by 33% revenue growth. Base business strength offset Ibuprofen headwinds, which is now nearing breakeven.
Solara Active Pharma Sciences Employee Stock Options
Solara Active Pharma Sciences Limited allotted 8,300 equity shares under its 2018 ESOP plan. The exercise of these options realized Rs. 0.31 Crore for the company.
- Value
- ₹0.31 Cr
Solara Active Pharma Sciences Q2 FY27 Results: Turns Profitable, Net Profit ₹28.5 Cr
Solara Active Pharma Sciences Ltd reported revenue from operations of ₹417.3 Cr (+33.1% YoY) and net profit of ₹28.5 Cr for Q2 FY27.
- Key figure
- Net profit ₹28.5 Cr
Solara Active Pharma Sciences Other Announcement
Solara Active Pharma received an ESG rating of 63 ('Strong' category) from Crisil ESG Ratings for the fiscal year 2026, an upgrade from the prior year.
Other annual general meeting announcements
All →Tasty Bite Eatables Annual General Meeting
Tasty Bite Eatables declared postal ballot results approving a material related-party transaction with Mars Food UK Limited for purchase of a capital asset. Promoter group did not vote and the resolution passed with 99.99% of votes cast in favour.
Unihealth Hospitals Annual General Meeting
Unihealth Hospitals reported postal ballot results: all three resolutions passed, covering a related-party loan-to-equity conversion with UMC Hospitals, variation of unutilised IPO proceeds, and migration from NSE Emerge to the main board. No rupee amount is stated for the approvals.
Vedanta Iron and Steel Annual General Meeting
Vedanta Iron and Steel seeks shareholder approval via postal ballot for seven material related party transaction resolutions. E-voting runs from 29 October to 27 November 2026.
GTPL Hathway Annual General Meeting
GTPL Hathway seeks shareholder approval by postal ballot to appoint Gurjeev Singh Kapoor as Non-Executive Director. E-voting runs November 1 to 30, 2026.
HEG Advanced Materials Annual General Meeting
HEG Advanced Materials seeks approval via postal ballot to appoint seven directors and fix MD Riju Jhunjhunwala's remuneration. E-voting runs October 29 to November 27, 2026.
Trident Texofab Annual General Meeting
Trident Texofab's EGM on 28 October 2026 sought approval for a statutory auditor to fill a casual vacancy. Only one ordinary resolution was tabled.